Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Sponsored by Zoetis

Sponsored By Zoetis


Advanced diagnostic tests helping identify IBV in Europe

The QX strain of infectious bronchitis virus (IBV) remains the most common variant of IBV in Europe, but the prevalence of the variant 02 strain appears to be on the increase, indicate results from the Zoetis diagnostic laboratory in France.

The results are based on more than 2,000 samples from 22 countries analyzed at the laboratory in 2017, Françoise Blond, DVM, a Zoetis laboratory manager in Brittany, France, told Poultry Health Today.

The test used for analysis is quantitative olymerase chain reaction (qPCR). It can identify multiple strains of IBV in one sample, and the results are ready in less than a week’s time, providing information that European producers can use to make better decisions about the IBV vaccines they use.

With molecular sequencing methods, only one dominant IBV strain can be identified, and it takes longer to get results than it does with qPCR, she said.

The QX strain has been around for about a decade, Blond continued. The increase in the variant 02 strain was found in only a few countries, particularly in Poland. Previously, this strain was thought to be restricted to countries in the Middle East.

One of the issues that remains with diagnostics is the inability to properly differentiate between the vaccine and field virus. If a producer is vaccinating with QX and the lab finds QX in submitted samples, it’s very hard to tell if the source is a vaccine or field strain, she explained.

When the lab finds a strain that isn’t part of the producer’s vaccination program in flocks with signs of respiratory disease, the virus at work is likely a field strain, and the best option is to include a homologous — a similar— strain in the vaccination schedule.

In that same vein, if a producer is in a region with high pressure from a certain IBV strain, a homologous vaccine strain would be the best vaccine choice for preventing IBV, Blond said — preferably in combination with one or two other strains to expand the protection range.

Editor’s note: This video interview, podcast and news article were developed independently by the editors of Poultry Health Today. They are presented here solely for their news value. The opinions and recommendations presented are not necessarily shared by the editors of Poultry Health Today or the interviewee’s employer.

Shareicon Pht 1
Share It
Diagnostic lab results suggest the variant 02 strain of infectious bronchitis virus (IBV) is becoming more prevalent in Europe, which may influence flock vaccination plans in some locations.

Click an icon to share this information with your industry contacts.

Posted on April 9, 2019

tags: , , , ,
  • How effective IBV surveillance can prevent ‘overvaccination’

    Consistent surveillance and analysis of infectious bronchitis virus (IBV) at poultry production facilities can guard against “overvaccination” — where too much vaccine virus in the environment causes a rolling reaction in flocks.

  • ‘Reverse genetics’ may offer new IBV vaccine targets

    Researchers at The Pirbright Institute in the UK report that a recent study provides evidence that mutations in the genetic code for non-structural proteins “offer a promising way” to make vaccines against infectious bronchitis virus (IBV) safer.

  • Why ‘vaccinated’ chickens still get infected with IBV — and what to do about it

    While many vaccines and vaccination programs effectively protect against the highly contagious infectious bronchitis virus in poultry, outbreaks of the disease still occur in vaccinated flocks.

  • Poultry industry can learn from COVID-19

    Biosecurity is not sufficient to control avian coronaviruses like infectious bronchitis in commercial poultry, no matter how good it is, said Mark Jackwood, PhD, a molecular virologist and professor of avian medicine at the University of Georgia.

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.